Yingping Chen, Xinpei Zhang, Lihui Gong, Zhenzhen Liang, Xiaosong Hu, Bo Xing, . . . Huakun Lv. (2023). Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Taylor & Francis Group.
Chicago Style (17th ed.) CitationYingping Chen, et al. Safety, Immunogenicity and Immune-persistence of Heterologous Prime-boost Immunization with BBIBP-CorV and ZF2001 Against SARS-CoV-2 in Healthy Adults Aged 18 Years or Older. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationYingping Chen, et al. Safety, Immunogenicity and Immune-persistence of Heterologous Prime-boost Immunization with BBIBP-CorV and ZF2001 Against SARS-CoV-2 in Healthy Adults Aged 18 Years or Older. Taylor & Francis Group, 2023.